# Certara, Inc.: financial statements, quarterly

CERT · Nasdaq · CIK 1827090 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cert.md) · [Financials](/companies/cert/financials.md) · [Filings](/companies/cert/filings.md) · [Insiders](/companies/cert/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cert/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [85.6](/filings/0001827090-24-000037.md) | [88.0 d](/filings/0001827090-26-000011.md) | [96.7](/filings/0001827090-25-000028.md) | [93.3](/filings/0001827090-25-000036.md) | [94.8](/filings/0001827090-25-000048.md) | [100 d](/filings/0001827090-26-000011.md) | [106](/filings/0001827090-26-000019.md) | [92.4](/filings/0001827090-26-000028.md) | [105](/filings/0001827090-25-000048.md) | [104 d](/filings/0001827090-26-000011.md) | [107](/filings/0001827090-26-000019.md) | [93.3](/filings/0001827090-26-000028.md) |
| Cost of revenue | $m | [35.9](/filings/0001827090-23-000021.md) | [34.1 d](/filings/0001827090-24-000006.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [9.0](/filings/0001827090-24-000037.md) | [8.0 d](/filings/0001827090-26-000011.md) | [12.0](/filings/0001827090-25-000028.md) | [9.1](/filings/0001827090-25-000036.md) | [8.3](/filings/0001827090-25-000048.md) | [7.8 d](/filings/0001827090-26-000011.md) | [10.5](/filings/0001827090-26-000019.md) | [9.0](/filings/0001827090-26-000028.md) | [10.3](/filings/0001827090-25-000048.md) | [11.3 d](/filings/0001827090-26-000011.md) | [12.3](/filings/0001827090-26-000019.md) | [9.7](/filings/0001827090-26-000028.md) |
| Operating income | $m | [(52.8)](/filings/0001827090-24-000037.md) | [(8.5) d](/filings/0001827090-26-000011.md) | [(1.3)](/filings/0001827090-25-000028.md) | [(9.0)](/filings/0001827090-25-000036.md) | [2.6](/filings/0001827090-25-000048.md) | [6.0 d](/filings/0001827090-26-000011.md) | [7.6](/filings/0001827090-26-000019.md) | [7.7](/filings/0001827090-26-000028.md) | [3.0](/filings/0001827090-25-000048.md) | [0.8 d](/filings/0001827090-26-000011.md) | [(4.3)](/filings/0001827090-26-000019.md) | [(0.2)](/filings/0001827090-26-000028.md) |
| Interest expense | $m | [5.9](/filings/0001827090-23-000021.md) | [5.9 d](/filings/0001827090-24-000006.md) | [5.8](/filings/0001827090-24-000013.md) | [5.6](/filings/0001827090-25-000036.md) | [5.2](/filings/0001827090-25-000048.md) | [5.0 d](/filings/0001827090-26-000011.md) | [4.8](/filings/0001827090-26-000019.md) | [4.8](/filings/0001827090-26-000028.md) | [5.0](/filings/0001827090-25-000048.md) | [5.1 d](/filings/0001827090-26-000011.md) | [4.9](/filings/0001827090-26-000019.md) | [5.0](/filings/0001827090-26-000028.md) |
| Income tax | $m | [(4.6)](/filings/0001827090-24-000037.md) | [0.1 d](/filings/0001827090-26-000011.md) | [(0.8)](/filings/0001827090-25-000028.md) | [0.3](/filings/0001827090-25-000036.md) | [(0.3)](/filings/0001827090-25-000048.md) | [(4.4) d](/filings/0001827090-26-000011.md) | [(0.2)](/filings/0001827090-26-000019.md) | [2.9](/filings/0001827090-26-000028.md) | [(1.8)](/filings/0001827090-25-000048.md) | [3.0 d](/filings/0001827090-26-000011.md) | [0.8](/filings/0001827090-26-000019.md) | [(0.3)](/filings/0001827090-26-000028.md) |
| Net income | $m | [(49.0)](/filings/0001827090-24-000037.md) | [(12.5) d](/filings/0001827090-26-000011.md) | [(4.7)](/filings/0001827090-25-000028.md) | [(12.6)](/filings/0001827090-25-000036.md) | [(1.4)](/filings/0001827090-25-000048.md) | [6.6 d](/filings/0001827090-26-000011.md) | [4.7](/filings/0001827090-26-000019.md) | [(2.0)](/filings/0001827090-26-000028.md) | [1.5](/filings/0001827090-25-000048.md) | [(5.9) d](/filings/0001827090-26-000011.md) | [(8.8)](/filings/0001827090-26-000019.md) | [(55.3)](/filings/0001827090-26-000028.md) |
| Diluted EPS | $ per share | [(0.31)](/filings/0001827090-24-000037.md) | not reported | [(0.03)](/filings/0001827090-25-000028.md) | [(0.08)](/filings/0001827090-25-000036.md) | [(0.01)](/filings/0001827090-25-000048.md) | not reported | [0.03](/filings/0001827090-26-000019.md) | [(0.01)](/filings/0001827090-26-000028.md) | [0.01](/filings/0001827090-25-000048.md) | not reported | [(0.06)](/filings/0001827090-26-000019.md) | [(0.36)](/filings/0001827090-26-000028.md) |
| Basic EPS | $ per share | [(0.31)](/filings/0001827090-24-000037.md) | not reported | [(0.03)](/filings/0001827090-25-000028.md) | [(0.08)](/filings/0001827090-25-000036.md) | [(0.01)](/filings/0001827090-25-000048.md) | not reported | [0.03](/filings/0001827090-26-000019.md) | [(0.01)](/filings/0001827090-26-000028.md) | [0.01](/filings/0001827090-25-000048.md) | not reported | [(0.06)](/filings/0001827090-26-000019.md) | [(0.36)](/filings/0001827090-26-000028.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [272](/filings/0001827090-23-000021.md) | [235](/filings/0001827090-25-000014.md) | [225](/filings/0001827090-24-000013.md) | [225](/filings/0001827090-24-000029.md) | [233](/filings/0001827090-24-000037.md) | [179](/filings/0001827090-26-000011.md) | [179](/filings/0001827090-25-000028.md) | [162](/filings/0001827090-25-000036.md) | [173](/filings/0001827090-25-000048.md) | [189](/filings/0001827090-26-000028.md) | [149](/filings/0001827090-26-000019.md) | [184](/filings/0001827090-26-000028.md) |
| Current assets | $m | [370](/filings/0001827090-23-000021.md) | [340](/filings/0001827090-25-000014.md) | [328](/filings/0001827090-24-000013.md) | [337](/filings/0001827090-24-000029.md) | [351](/filings/0001827090-24-000037.md) | [311](/filings/0001827090-26-000011.md) | [300](/filings/0001827090-25-000028.md) | [281](/filings/0001827090-25-000036.md) | [283](/filings/0001827090-25-000048.md) | [315](/filings/0001827090-26-000028.md) | [271](/filings/0001827090-26-000019.md) | [312](/filings/0001827090-26-000028.md) |
| Total assets | $m | [1,527](/filings/0001827090-23-000021.md) | [1,563](/filings/0001827090-25-000014.md) | [1,542](/filings/0001827090-24-000013.md) | [1,540](/filings/0001827090-24-000029.md) | [1,543](/filings/0001827090-24-000037.md) | [1,575](/filings/0001827090-26-000011.md) | [1,561](/filings/0001827090-25-000028.md) | [1,543](/filings/0001827090-25-000036.md) | [1,536](/filings/0001827090-25-000048.md) | [1,557](/filings/0001827090-26-000028.md) | [1,500](/filings/0001827090-26-000019.md) | [1,400](/filings/0001827090-26-000028.md) |
| Current liabilities | $m | [105](/filings/0001827090-23-000021.md) | [130](/filings/0001827090-25-000014.md) | [101](/filings/0001827090-24-000013.md) | [129](/filings/0001827090-24-000029.md) | [123](/filings/0001827090-24-000037.md) | [146](/filings/0001827090-26-000011.md) | [108](/filings/0001827090-25-000028.md) | [130](/filings/0001827090-25-000036.md) | [136](/filings/0001827090-25-000048.md) | [153](/filings/0001827090-26-000028.md) | [144](/filings/0001827090-26-000019.md) | [122](/filings/0001827090-26-000028.md) |
| Total liabilities | $m | [475](/filings/0001827090-23-000021.md) | [516](/filings/0001827090-25-000014.md) | [488](/filings/0001827090-24-000013.md) | [496](/filings/0001827090-24-000029.md) | [490](/filings/0001827090-24-000037.md) | [516](/filings/0001827090-26-000011.md) | [477](/filings/0001827090-25-000028.md) | [473](/filings/0001827090-25-000036.md) | [471](/filings/0001827090-25-000048.md) | [494](/filings/0001827090-26-000028.md) | [483](/filings/0001827090-26-000019.md) | [433](/filings/0001827090-26-000028.md) |
| Long-term debt | $m | [289](/filings/0001827090-23-000021.md) | [288](/filings/0001827090-25-000014.md) | [288](/filings/0001827090-24-000013.md) | [294](/filings/0001827090-24-000029.md) | [293](/filings/0001827090-24-000037.md) | [292](/filings/0001827090-26-000011.md) | [292](/filings/0001827090-25-000028.md) | [291](/filings/0001827090-25-000036.md) | [291](/filings/0001827090-25-000048.md) | [290](/filings/0001827090-26-000028.md) | [290](/filings/0001827090-26-000019.md) | [289](/filings/0001827090-26-000028.md) |
| Current portion of debt | $m | [3.0](/filings/0001827090-23-000021.md) | [3.0](/filings/0001827090-25-000014.md) | [3.0](/filings/0001827090-24-000013.md) | [3.0](/filings/0001827090-24-000029.md) | [3.0](/filings/0001827090-24-000037.md) | [3.0](/filings/0001827090-26-000011.md) | [3.0](/filings/0001827090-25-000028.md) | [3.0](/filings/0001827090-25-000036.md) | [3.0](/filings/0001827090-25-000048.md) | [3.0](/filings/0001827090-26-000028.md) | [3.0](/filings/0001827090-26-000019.md) | [3.0](/filings/0001827090-26-000028.md) |
| Shareholders' equity | $m | [1,052](/filings/0001827090-24-000037.md) | [1,047](/filings/0001827090-26-000011.md) | [1,054](/filings/0001827090-25-000036.md) | [1,043](/filings/0001827090-25-000048.md) | [1,053](/filings/0001827090-25-000048.md) | [1,059](/filings/0001827090-26-000028.md) | [1,084](/filings/0001827090-26-000028.md) | [1,071](/filings/0001827090-26-000028.md) | [1,065](/filings/0001827090-25-000048.md) | [1,063](/filings/0001827090-26-000028.md) | [1,017](/filings/0001827090-26-000028.md) | [967](/filings/0001827090-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [31.4 d](/filings/0001827090-24-000037.md) | [23.3 d](/filings/0001827090-26-000011.md) | [4.3](/filings/0001827090-25-000028.md) | [9.8 d](/filings/0001827090-25-000036.md) | [17.0 d](/filings/0001827090-25-000048.md) | [49.4 d](/filings/0001827090-26-000011.md) | [17.4](/filings/0001827090-26-000019.md) | [17.8 d](/filings/0001827090-26-000028.md) | [32.3 d](/filings/0001827090-25-000048.md) | [28.8 d](/filings/0001827090-26-000011.md) | [11.7](/filings/0001827090-26-000019.md) | [10.0 d](/filings/0001827090-26-000028.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001827090-24-000037.md) | [0.9 d](/filings/0001827090-26-000011.md) | [0.6](/filings/0001827090-25-000028.md) | [0.4 d](/filings/0001827090-25-000036.md) | [0.2 d](/filings/0001827090-25-000048.md) | [0.4 d](/filings/0001827090-26-000011.md) | [0.6](/filings/0001827090-26-000019.md) | [(0.1) d](/filings/0001827090-26-000028.md) | [0.2 d](/filings/0001827090-25-000048.md) | [1.0 d](/filings/0001827090-26-000011.md) | [0.6](/filings/0001827090-26-000019.md) | [0.6 d](/filings/0001827090-26-000028.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001827090-25-000048.md) | [0.0 d](/filings/0001827090-26-000011.md) | [0.0](/filings/0001827090-26-000019.md) | [25.0 d](/filings/0001827090-26-000028.md) | [13.7 d](/filings/0001827090-25-000048.md) | [3.9 d](/filings/0001827090-26-000011.md) | [40.0](/filings/0001827090-26-000019.md) | [17.4 d](/filings/0001827090-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [160](/filings/0001827090-23-000021.md) | [160](/filings/0001827090-24-000013.md) | [160](/filings/0001827090-24-000029.md) | [159](/filings/0001827090-24-000037.md) | [160](/filings/0001827090-25-000028.md) | [161](/filings/0001827090-25-000036.md) | [161](/filings/0001827090-25-000048.md) | [161](/filings/0001827090-26-000019.md) | [162](/filings/0001827090-26-000028.md) | [161](/filings/0001827090-25-000048.md) | [158](/filings/0001827090-26-000019.md) | [154](/filings/0001827090-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 152,538,780 at 2026-08-01, from the cover of the [10-Q filed 2026-08-04](/filings/0001827090-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.